secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCULAR THERAPEUTIX, INC (OCUL)
CIK:        0001393434
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001104659-24-071530
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocular Therapeutix shareholders approve doubling authorized shares to 400M and increasing equity plan by 7M shares
--------------------------------------------------------------------------------

- Stockholders approved amendment to increase authorized common stock from 200M to 400M shares.
- Stockholders approved Amendment No. 3 to 2021 Stock Incentive Plan, adding 7M shares for issuance.
- Elected Adrienne L. Graves, Ph.D. and Charles Warden as Class I directors for term ending 2027.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY 2024; votes: 119.6M for, 0.86M against.
- Non-binding advisory vote on executive compensation passed with 76.3M for, 9.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393434/000110465924071530/0001104659-24-071530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393434/000110465924071530/tm2417152d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-071530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer